deoxycytidine has been researched along with Carcinosarcoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, S; Liang, D; Liu, D; Liu, Q; Ma, J; Yan, C; Yang, Z | 1 |
| Fujimoto, D; Goi, T; Iida, A; Ishida, M; Kimura, T; Sato, Y; Togawa, T | 1 |
| Bharti, JN; Soni, SC; Sureka, B; Varshney, VK | 1 |
| Antoine, M; Bonnette, P; Cadranel, J; Cazes, A; Duruisseaux, M; Girard, N; Mazieres, J; Monnet, I; Ung, M; Vieira, T; Wislez, M | 1 |
| Fujiwara, K; Hanaoka, T; Hasegawa, K; Iwasa, N; Kurosaki, A; Nagao, S; Nishikawa, T | 1 |
| Abulafia, O; Blessing, JA; Miller, BE; Richards, WE; Secord, AA; Shahin, MS; Stehman, FB; Van Le, L; Warshal, DP; Yamada, SD | 1 |
| Liu, TG; Zhu, H; Zhu, WY | 1 |
| Hoshi, S; Kobayashi, T; Muto, A; Ono, K; Sasaki, M; Saso, S; Sugano, O; Suzuki, K; Tukigi, M | 1 |
| Behringer, D; Gelos, M; Mann, B; Philippou, S | 1 |
| Froehner, M; Gaertner, HJ; Manseck, A; Wirth, MP | 1 |
3 review(s) available for deoxycytidine and Carcinosarcoma
| Article | Year |
|---|---|
Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Middle Aged; Pancreatic Neoplasms; Pancreaticoduodenectomy; Recurrence | 2012 |
Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapy.
Topics: Antineoplastic Agents; Carboplatin; Carcinosarcoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Remission Induction; Urinary Bladder Neoplasms | 2007 |
Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature.
Topics: Antimetabolites, Antineoplastic; Carcinosarcoma; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Prognosis | 2008 |
1 trial(s) available for deoxycytidine and Carcinosarcoma
| Article | Year |
|---|---|
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Uterine Neoplasms | 2010 |
6 other study(ies) available for deoxycytidine and Carcinosarcoma
| Article | Year |
|---|---|
Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma.
Topics: Carcinosarcoma; Deoxycytidine; Doxorubicin; Ferroptosis; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Prognosis | 2022 |
Sarcomatoid carcinoma of the pancreas with rare long-term survival: a case report.
Topics: Carcinosarcoma; Chemotherapy, Adjuvant; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Time Factors; Treatment Outcome | 2020 |
Gallbladder Carcinosarcoma with Mirizzi Syndrome: a Rare Presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Chemotherapy, Adjuvant; Cholecystectomy, Laparoscopic; Cisplatin; Deoxycytidine; Gallbladder; Gallbladder Neoplasms; Gemcitabine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mirizzi Syndrome; Treatment Outcome | 2019 |
Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Deoxycytidine; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gemcitabine; Giant Cell Tumors; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Quinazolines; Retrospective Studies; Sarcoma; Survival Rate; Taxoids; Vinblastine; Vinorelbine | 2013 |
The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cystadenocarcinoma, Serous; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Endometrial Neoplasms; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Polyethylene Glycols; Prognosis; Remission Induction; Retrospective Studies; Survival Rate | 2016 |
Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Male; Remission Induction; Urinary Bladder Neoplasms | 2001 |